TCM Daoyin for Anxiety/Depression: Psychological Effects and Biological Mechanisms
Launched by SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE · Apr 9, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a Traditional Chinese Medicine exercise called Daoyin on symptoms of anxiety and depression. Over 12 weeks, 20 participants will engage in this exercise to see if it helps improve their mood and reduce anxiety. Researchers will measure changes in anxiety and depression scores at the start, after 12 weeks, and again after an additional 12-week follow-up period. They will also look at participants' sleep quality and some biological markers to better understand how the exercise might work.
To be eligible for this trial, participants should be between 18 and 65 years old and have symptoms of anxiety and depression that meet specific criteria. They should not have used any psychiatric medications in the past six months and must be able to communicate and engage in daily activities independently. Participants will need to provide some blood and stool samples during the study to help with research. This trial is currently recruiting and aims to provide insights into how TCM can support mental health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Primary symptoms of anxiety and depression, with a Hamilton Anxiety Rating Scale (HAMA-14) score between 14 and 29 and a Hamilton Depression Rating Scale (HAMD-17) score between 7 and 14.
- • No prior use of psychotropic medication, or at least six months since discontinuation.
- • Aged 18 to 65 years (male or female).
- • Clear consciousness and normal cognitive function, with the ability to communicate effectively, read, express thoughts, and engage in daily activities independently.
- • Willing and able to comply with blood and stool sample collection.
- • Voluntary participation, with signed informed consent provided before enrollment.
- Exclusion Criteria:
- • Diagnosed anxiety disorder or depressive disorder based on ICD-10 criteria.
- • Bipolar disorder, psychotic disorders (e.g., schizophrenia), or organic mental disorders (e.g., Alzheimer's disease).
- • History of alcohol or substance use disorder within the past year, current psychiatric medication use, or high suicide risk.
- • Severe or unstable medical conditions, including immune or endocrine disorders or other serious illnesses.
- • Physical or psychological limitations preventing participation in the TCM Daoyin intervention.
- • Pregnant or breastfeeding women.
About Shanghai University Of Traditional Chinese Medicine
Shanghai University of Traditional Chinese Medicine is a leading institution dedicated to advancing the field of traditional Chinese medicine through rigorous research and innovative clinical practices. With a strong emphasis on integrating traditional methodologies with modern scientific approaches, the university aims to enhance healthcare outcomes and promote holistic wellness. As a sponsor of clinical trials, it is committed to exploring the efficacy and safety of traditional therapies, contributing to evidence-based practices, and fostering collaborations that bridge Eastern and Western medical paradigms. The university's focus on education, research, and community engagement positions it as a pivotal player in the global health landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Patients applied
Trial Officials
Ying Lu, Master
Principal Investigator
Shanghai Qigong Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported